PMID: 16361259

Gross CH, Abdul-Manan N, Fulghum J, Lippke J, Liu X, Prabhakar P, Brennan D, Willis MS, Faerman C, Connelly P, Raybuck S, Moore J
Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.
J Biol Chem. 2006 Feb 17;281(7):4058-68. Epub 2005 Dec 16., 2006-02-17 [PubMed]
Sentences
No. Mutations Sentence Comment
10 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:10:19
status: NEW
view ABCC7 p.Gly551Asp details
Interestingly, the G551D gating mutation has an exaggerated nonlinear phase compared with the wild type and may indicate this mutation affects the ability of NBD1 to dimerize. Login to comment
32 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:32:48
status: NEW
view ABCC7 p.Gly551Asp details
In contrast, the second most common CF mutation G551D is only defective in channel function (6) and has a prevalence of 2-7% in the CF population (7). Login to comment
60 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:60:4
status: NEW
view ABCC7 p.Gly551Asp details
The G551D gating mutation has an exaggerated nonlinear phase as compared with wild type, and may indicate this mutation affects NBD1 ability to form dimers. Login to comment
103 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:103:34
status: NEW
view ABCC7 p.Gly551Asp details
The mNBD1 proteins (wild type and G551D) were purified to homogeneity as judged by a Coomassie-stained SDS-PAGE gel (Fig. 1A). Login to comment
104 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:104:47
status: NEW
view ABCC7 p.Gly551Asp details
A total of nine mNBD1 wild type and four mNBD1 G551D independent protein samples were purified for this study. Login to comment
132 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:132:73
status: NEW
view ABCC7 p.Gly551Asp details
A, Coomassie-stained SDS-PAGE of native mouse NBD1 (mNBD1) wild type and G551D mutant proteins (2 ␮g of protein). Login to comment
191 ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 16361259:191:90
status: NEW
view ABCC7 p.Lys1250Ala details
B, thin layer chromatography plateshowingtheAKactivityofthewild-typehNBD2 protein and the K1250A mutant protein. Login to comment
196 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:196:328
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:196:675
status: NEW
view ABCC7 p.Gly551Asp details
TABLE 1 Wild-type and mutant protein kinetic parameters for AK activity Enzymea Mutation ATP AMP ADP Km b,c Vmax b,c Km b,c Vmax b,c Km b,c Vmax b,c ␮M ␮M/min ␮M ␮M/min ␮M ␮M/min mNBD1 WT 30 Ϯ 2 1.2 Ϯ 0.01 30 Ϯ 4 0.9 Ϯ 0.02 450 Ϯ 60 1.4 Ϯ 0.06 mNBD1 G551D 80 Ϯ 7 0.4 Ϯ 0.02 70 Ϯ 7 0.4 Ϯ 0.02 360 Ϯ 50 1.0 Ϯ 0.05 hNBD1 WT 80 Ϯ 5 0.7 Ϯ 0.02 60 Ϯ 7 0.7 Ϯ 0.03 300 Ϯ 20 1.0 Ϯ 0.02 hNBD2 WT 70 Ϯ 3 0.6 Ϯ 0.01 40 Ϯ 5 0.7 Ϯ 0.03 280 Ϯ 20 0.7 Ϯ 0.02 a Enzyme concentrations are mNBD1 WT (900 nM), G551D (1800 nM), hNBD1 (4.7 nM), hNBD2 (30 nM). Login to comment
205 ABCC7 p.Lys1250Ala
X
ABCC7 p.Lys1250Ala 16361259:205:11
status: NEW
view ABCC7 p.Lys1250Ala details
The hNBD2 (K1250A) mutant result is in agreement with the results reported by Randak and Welsh (16). Login to comment
240 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:240:68
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 16361259:240:61
status: NEW
view ABCC7 p.Lys464Ala details
Next, we wanted to examine three key CFTR residues in mNBD1 (K464A, G551D, and ⌬F508) to determine what effect these mutations had on their ability to form homodimers or alter AK activity. Login to comment
241 ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 16361259:241:107
status: NEW
view ABCC7 p.Lys464Ala details
All three mutant proteins overexpressed, however, during their purifications two mutants (⌬F508 and K464A) were problematic. Login to comment
244 ABCC7 p.Lys464Ala
X
ABCC7 p.Lys464Ala 16361259:244:85
status: NEW
view ABCC7 p.Lys464Ala details
Because of the chaperone contamination we were forced to abandon our analysis of the K464A and ⌬F508 proteins. Login to comment
245 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:245:23
status: NEW
view ABCC7 p.Gly551Asp details
In contrast, the mNBD1 G551D mutant protein purified with the same characteristics as the wild-type protein. Login to comment
246 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:246:19
status: NEW
view ABCC7 p.Gly551Asp details
The AK activity of G551D mutant was measured as a function of protein concentration (Fig. 6A). Login to comment
247 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:247:28
status: NEW
view ABCC7 p.Gly551Asp details
From this data, we find the G551D gating mutation lacks AK activity at low protein concentrations (Ͻ250 nM) when compared with the wild type protein, suggesting the mutation affects the ability of the NBD1 to dimerize. Login to comment
248 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:248:57
status: NEW
view ABCC7 p.Gly551Asp details
This was confirmed with two independently purified mNBD1 G551D samples. Login to comment
249 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:249:32
status: NEW
view ABCC7 p.Gly551Asp details
The kinetic parameters of mNBD1 G551D protein (1800 nM) were determined (Table 1) at saturating ATP (2 mM). Login to comment
250 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:250:202
status: NEW
view ABCC7 p.Gly551Asp details
The apparent AMP Km was 70 ␮M and Vmax was 0.4 ␮M/min. At high AMP (400 ␮M) the apparent ATP Km was 80 ␮M and Vmax was 0.4 ␮M/min. At high protein concentrations, the G551D mutation results in only a modest decrease in catalysis and 2-fold decrease in substrate affinity when compared with wild type protein. Login to comment
251 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:251:23
status: NEW
view ABCC7 p.Gly551Asp details
These data suggest the G551D mutation does not significantly disrupt catalytic function directly but rather the mutation may reduce the affinity between the two NBDs in the intact CFTR protein. Login to comment
253 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:253:20
status: NEW
view ABCC7 p.Gly551Asp details
We surmise that the G551D mutation renders NBD1 unable to associate or rearrange productively with NBD2 upon nucleotide substrate binding and that this subsequently leads to a defect in Cl-ion transport. Login to comment
255 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:255:67
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:255:186
status: NEW
view ABCC7 p.Gly551Asp details
However, we cannot formally rule out the possibility that the CFTR G551D folds less efficiently than the wild-type protein (i.e. that there are a lower percentage of active molecules in G551D preparation as compared with wild type preparation) as a good active site titrating compound is not available. Login to comment
266 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 16361259:266:35
status: NEW
view ABCC7 p.Gly551Asp details
A, mNBD1 wild type (square), mNBD1 G551D mutant (triangle) hNBD1 (B) and hNBD2 (C) proteins are shown. Login to comment